Viridian Therapeutics, Inc./DE Interest Expense, Related Party
Viridian Therapeutics, Inc./DE (VRDN) reported Interest Expense, Related Party of $19.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2015-05-15
- Viridian Therapeutics, Inc./DE interest expense, related party for the quarter ending 2015-03-31 was $19.00K.
- Viridian Therapeutics, Inc./DE interest expense, related party for the quarter ending 2014-06-30 was $476.00K, a 0.42% increase year-over-year.
- Viridian Therapeutics, Inc./DE interest expense, related party for the quarter ending 2013-06-30 was $474.00K.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month |
|---|---|---|
| 2015-03-31 | $19.00K 10-Q · filed 2015-05-15 | |
| 2014-06-30 | $476.00K 10-Q · filed 2014-08-14 | $1.01M 10-Q · filed 2014-08-14 |
| 2013-06-30 | $474.00K 10-Q · filed 2014-08-14 | $924.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |